image
Cyclacel Pharmaceuticals, Inc. CYCC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.374
-4.91 %
$ 2.35 M
Market Cap
-0.02
P/E
INCOME STATEMENT
420 K REVENUE
0.00%
Growth Rates
1Year 0.00%
3Years 0.00%
5Years 22.87%
7Years -9.47%
10Years -9.05%
-25.5 M OPERATING INCOME
7.97%
Growth Rates
1Year 7.97%
3Years -33.76%
5Years -21.66%
7Years -8.75%
10Years -3.54%
-22.6 M NET INCOME
-6.40%
Growth Rates
1Year -6.40%
3Years -38.74%
5Years -25.35%
7Years -9.71%
10Years -8.31%
EFFICIENCY
Earnings Waterfall Cyclacel Pharmaceuticals, Inc.
image
Revenue 420 K
Cost Of Revenue 31 K
Gross Profit 389 K
Operating Expenses 25.9 M
Operating Income -25.5 M
Other Expenses -2.9 M
Net Income -22.6 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000
REVENUE
Revenue 0.4 0 0 0 0 0.1 0 0.8 1.9 1.7 1.1 69 K 0.7 0.7 0.9 0.9 0.1 0.4 0.8 62 K 0.2 0 30 K 98 K
GROSS PROFIT
Cost Of Revenue 31 K 32 K 43 K 20 K 20 K 4.3 32 K 9.5 12.4 18.3 11.3 6.6 0.4 0.4 0.5 0.4 19.6 21.2 0 0 0 0 0 0
Gross Profit 0.4 32 K 43 K 20 K 20 K (4.2) 32 K (8.6) (10.4) (16.5) (10.2) (6.5) 0.3 0.3 0.4 0.4 (19.4) (20.8) 0.8 62 K 0.2 0 30 K 98 K
OPERATING INCOME
Operating Expenses 25.9 27.7 22.9 10.6 9.7 9.7 9.5 15.0 18.1 24.2 19.1 15.2 16.7 16.5 18.3 34.2 11.5 12.3 30.5 26.6 18.0 19.6 19.9 13.7
Selling, General and Administrative Expenses 6.7 7.4 7.5 5.9 5.0 5.4 5.3 5.5 5.8 5.9 7.8 8.6 7.5 10.1 8.5 15.4 11.5 12.3 9.7 6.9 4.3 5.0 5.2 2.4
Research and Development Expenses 19.2 20.3 15.5 4.8 4.7 4.3 4.2 9.5 12.4 18.3 11.3 6.6 9.2 6.4 9.8 18.9 10 K 0.2 13.8 19.7 13.7 14.7 14.7 11.3
Operating Income (25.5) (27.7) (22.9) (10.6) (9.7) (9.5) (9.5) (14.2) (16.2) (22.4) (18.0) (15.1) (16.4) (16.3) (18.3) (42.2) (32.5) (33.4) (29.7) (26.5) (17.8) (19.6) (19.9) (13.6)
PRE-TAX INCOME
Interest Income Expense 0 (2.0) 0 0 0 0 0 0 0 0 0 0 0 43 K 0.2 0.3 0 0 0 0 0 0 0 0
Total Other Income 98 K 1.7 0.2 1.0 0.6 0.9 1.0 0.4 (0.3) (0.2) 6.1 4 K 0.6 0.2 (2.6) (8.4) 4.9 1.6 0.8 1.3 1 K 0 19.9 0.6
Pre-Tax Income (25.6) (25.9) (22.7) (9.7) (9.1) (8.6) (8.5) (13.8) (16.5) (22.6) (11.9) (15.1) (15.8) (16.7) (20.5) (42.1) (26.1) (31.5) (37.1) (27.2) (17.8) 0 0 (12.9)
NET INCOME
Tax Provision (3.0) (4.7) (3.8) (1.2) (1.3) (1.3) (1.0) (2.0) (2.1) (3.2) (1.7) (1.4) (0.6) (0.7) (0.9) (1.7) (2.0) (2.2) (0.3) 13.1 0.6 19.5 19.5 0
Net Income (22.6) (21.2) (18.9) (8.4) (7.8) (7.3) (7.5) (11.8) (14.3) (19.4) (10.2) (13.2) (15.2) (16.0) (19.6) (40.4) (24.1) (29.3) (29.4) (39.6) (18.5) (19.5) (19.5) (12.9)
EPS 26.8 32.2 31.7 34.9 144 12.1 19.6 68.8 106 212 161 440 509 711 1.48 K 3.32 K 2.03 K 3.67 K 7.42 K 5.35 K 2.1 K 4.91 K 4.92 K 3.27 K